Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Stock Options Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of stock option awards granted with the following assumptions:

	Year Ended December 31,
	2024		2023	2022
Expected term (in years)	5.27 - 6.74		5.27 - 6.25	2.92 - 6.33
Expected volatility	68.27% - 70.57%		68.74% - 81.98%	65.20% - 81.68%
Risk-free interest rate	3.43% - 4.47%		3.47% - 4.67%	1.47% - 4.37%
Expected dividend yield		—	—	—

Schedule of Nonvested Share Activity

The following table provides a summary of the unvested common stock awards activity during the year ended December 31, 2024.

	Number of Shares			Weighted Average Grant Date Fair Value Per Share
Unvested common stock as of December 31, 2023		747,679		$	16.00
Vested		(636,647	)	$	16.00
Forfeiture		(28,751	)	$	16.00
Unvested common stock as of December 31, 2024		82,281		$	16.00

Summary of Share-based Compensation Expense Recorded in The Accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss

Share-based compensation expense recorded in the accompanying statements of operations is as follows (in thousands):

	Year Ended December 31,
	2024		2023		2022
Research and development expense	$	16,710	$	14,381	$	8,486
Selling, general and administrative expense		31,553		24,960		18,756
Total share-based compensation expense	$	48,263	$	39,341	$	27,242

2021 Equity Incentive Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule Of Stock Options

The following table provides a summary of stock option activity during the year ended December 31, 2024.

	Options			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2023		10,211,758		$	17.10
Granted		2,915,362		$	14.28
Exercised		(172,163	)	$	13.18			$	401.5
Forfeiture		(827,522	)	$	16.84
Outstanding at December 31, 2024		12,127,435		$	16.50		7.5	$	748.5
Vested and expected to vest at December 31, 2024		12,127,435		$	16.50		7.5	$	748.5
Exercisable at December 31, 2024		7,610,570		$	16.66		7.0	$	431.2

Summary of Restricted Stock Units Activity

The following table provides a summary of restricted stock units activity under the 2021 Plan during the year ended December 31, 2024:

	Number of Shares			Weighted Average Grant Date Fair Value Per Share
Unvested restricted stock units at December 31, 2023		1,031,545		$	18.27
Granted		1,640,180		$	14.35
Vested		(680,963	)	$	16.48
Forfeiture		(216,475	)	$	16.22
Unvested restricted stock units at December 31, 2024		1,774,287		$	15.58